Skip to content
10-Q

Quarterly Report

Sana Biotechnology, Inc. SANA

0001193125-26-216769

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 278.29M sh
Shares Diluted Q1 2026 · Mar 31, 2026 276.86M sh
Shares Diluted Q1 2026 · Mar 31, 2025 237.58M sh
Capex Q1 2026 · Mar 31, 2026 $288K
Capex Q1 2026 · Mar 31, 2025 $136K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$37.38M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$48.66M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $83.8M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $71.87M
Stockholders Equity Q1 2026 · Mar 31, 2026 $119.24M
Stockholders Equity Q1 2026 · Dec 31, 2025 $160.88M
Stockholders Equity Q1 2026 · Mar 31, 2025 $209.08M
Stockholders Equity Q1 2026 · Dec 31, 2024 $250.5M
Current Liabilities Q1 2026 · Mar 31, 2026 $86.27M
Current Liabilities Q1 2026 · Dec 31, 2025 $78.73M
Total Liabilities Q1 2026 · Mar 31, 2026 $254.35M
Total Liabilities Q1 2026 · Dec 31, 2025 $256.01M
Current Assets Q1 2026 · Mar 31, 2026 $111.69M
Current Assets Q1 2026 · Dec 31, 2025 $148.68M
Total Assets Q1 2026 · Mar 31, 2026 $373.59M
Total Assets Q1 2026 · Dec 31, 2025 $416.89M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.17
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.21
Eps Basic Q1 2026 · Mar 31, 2026 −$0.17
Eps Basic Q1 2026 · Mar 31, 2025 −$0.21
Sga Expense Q1 2026 · Mar 31, 2026 $11.46M
Sga Expense Q1 2026 · Mar 31, 2025 $11.48M
Rd Expense Q1 2026 · Mar 31, 2026 $28.72M
Rd Expense Q1 2026 · Mar 31, 2025 $37.19M
Net Income Q1 2026 · Mar 31, 2026 −$47.21M
Net Income Q1 2026 · Mar 31, 2025 −$49.39M
Operating Income Q1 2026 · Mar 31, 2026 −$48.61M
Operating Income Q1 2026 · Mar 31, 2025 −$50.63M